Aegerion Pharmaceuticals (AEGR) Plans Common Stock Offering

Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases, today announced that it intends to offer for sale its common stock in an underwritten public offering. All shares in the offering are being sold by Aegerion. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karman Line Acquisition closes $200M IPO on Nasdaq
• Amylyx prices $500M stock offering at $35.50 per share
• Aveanna selling stockholders launch 15M share secondary offering